China's universities drive critical tech patents at 8× U.S. rate, reshaping innovation landscape

The National Bureau of Economic Research study, conducted by Harvard Business School professor Josh Lerner and co-authors, analyzed nearly 14 million Chinese patents to map innovation in 14 technology areas designated as critical by the Pentagon: advanced computing, space technology, AI, hypersonics, and biotech. The central finding challenges the prevailing assumption that Chinese innovation is driven by a small number of elite corporations. Instead, Chinese universities account for more than a quarter of the country's inventions in these critical fields—a share 8× the U.S. university rate of 3.3%. State-owned enterprises and the government together account for only 4%, indicating a radically different innovation ecosystem from what researchers expected to find.

Lerner told Fortune his team had been "programmed" to expect major corporations like Huawei and Tencent to lead Chinese innovation through patents, mirroring the IBM and Samsung model in the United States. Instead, they discovered innovation "much more diverse—spread out across the parties," with universities "more represented" in China's patent system than anywhere else in the country. This pattern inverts the U.S. system, where academic patenting remains "more of a sideshow." Using four text-based measures of patent novelty and scientific relevance, the authors found no evidence that China's patent boom sacrificed quality. The share of Chinese critical-technology patents containing "disruptive" technical language jumped from under 2% in the early 1990s to 16% by 2022, closing in on the American share of roughly 20%.

The governance difference is equally striking. Beijing's role in university research is "coordinative rather than directly productive"—the state steers research through funding and priorities while universities retain autonomy. Lerner contrasted this with Harvard's public legal battles with the U.S. administration over research funding, suggesting Chinese universities face different pressures. This structural asymmetry matters because American federal research support is shrinking. The Trump administration moved to cut $4 billion from NIH's reimbursement of universities' research overhead costs, capping a rate that had typically run 50–60% at just 15%. By April, the administration had formally terminated 1,392 NIH grants worth $539 million in unspent obligations, while the National Science Foundation cancelled or suspended nearly 2,000 awards of its own. The Brennan Center for Justice estimates total NIH and NSF cuts and freezes at more than $3 billion since 2025, with roughly $1.4 billion still frozen or unresolved. Some terminations have been reversed by courts, but the underlying policy fights continue on a grant-by-grant basis.

The timing is critical. Lerner warned that "you don't really see the consequences until perhaps years or even decades afterwards, just given the very long-run nature of this process." The immediate evidence of China's advance is visible: in June, Zhejiang University—the alma mater of DeepSeek founder Liang Wenfeng—claimed the top spot in the Nature Index Research Leaders, a closely watched measure of high-quality research output, for the first time since the index began tracking universities in 2015. Harvard fell to second place among academic institutions, and to third when the Chinese Academy of Sciences (a government research body) is included. Nine of the top 10 academic institutions globally are now Chinese; five years ago, eight of the top 10 were American. China surpassed the U.S. in total R&D spending for the first time in 2024, investing $1.03 trillion to America's $1.01 trillion, having grown R&D spending at more than 14% annually since 2004—more than double the U.S. pace.

Some analysts urge caution in interpreting the patent data. Dan Wang, a China analyst at Eurasia Group, noted that commercialization rates for Chinese university patents remain low and few are filed overseas, while companies like Nvidia and Google drive "exceptionally strong" R&D in the United States. However, Wang also highlighted a blind spot in U.S. policy: Washington's focus on sanctioning a handful of "national champions" like Huawei and Tencent overlooks "the real base for China's technological upgrading"—decentralized networks of universities, suppliers, and state-owned enterprises. Wang estimates there are 18,000 state-designated "little giant" firms working on components and materials alone, suggesting that "sanctioning a few major firms alone is unlikely to halt the broader ecosystem."